Cargando…
Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study
According to the Center for Disease Control and Prevention, as of August 23, 94 countries had confirmed 42,954 Monkeypox Virus cases. As specific monkeypox drugs are not yet developed, the treatment depends on repurposed FDA-approved drugs. According to a recent study, the Monkeypox outbreak is caus...
Autores principales: | Srivastava, Varshita, Naik, Biswajit, Godara, Priya, Das, Dorothy, Mattaparthi, Venkata Satish Kumar, Prusty, Dhaneswar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116100/ https://www.ncbi.nlm.nih.gov/pubmed/37079243 http://dx.doi.org/10.1007/s11030-023-10636-4 |
Ejemplares similares
-
Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach
por: Singh, Swati, et al.
Publicado: (2022) -
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
por: Naik, Biswajit, et al.
Publicado: (2020) -
FDA approved vaccines for monkeypox: Current eminence
por: Chopra, Hitesh, et al.
Publicado: (2022) -
High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19
por: Ojha, Rupal, et al.
Publicado: (2020) -
Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective
por: Sun, Wellington
Publicado: (2023)